Cargando…
Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
OBJECTIVE: To evaluate efficacy and tolerability of adjunctive lacosamide in children and adolescents with uncontrolled focal (partial-onset) seizures. METHODS: In this double-blind trial (SP0969; NCT01921205), patients (age ≥4–<17 years) with uncontrolled focal seizures were randomized (1:1) to...
Autores principales: | Farkas, Viktor, Steinborn, Barbara, Flamini, J. Robert, Zhang, Ying, Yuen, Nancy, Borghs, Simon, Bozorg, Ali, Daniels, Tony, Martin, Paul, Carney, Hannah C., Dimova, Svetlana, Scheffer, Ingrid E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808531/ https://www.ncbi.nlm.nih.gov/pubmed/31462582 http://dx.doi.org/10.1212/WNL.0000000000008126 |
Ejemplares similares
-
Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
por: Jin, Yang, et al.
Publicado: (2023) -
Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
por: Sawh, Sonja C., et al.
Publicado: (2013) -
Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
por: Farkas, Mark Kristof, et al.
Publicado: (2023) -
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials
por: Ryvlin, Philippe, et al.
Publicado: (2022) -
Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam
por: Mukuria, Clara, et al.
Publicado: (2016)